Medicine News

• Allergan Resolves United States Government Investigation Of Past Sales And Marketing Pra ...
  Fri, 03 September 2010
  Allergan, Inc. (NYSE: AGN) announced that it has reached a resolution with the United States Department of Justice (DOJ) regarding the previously reported Government investigation into Allergan's past U.S. sales and marketing practices relating to certain therapeutic uses of BOTOX (onabotulinumtoxinA)...
• Halozyme Begins Phase 2 Clinical Trials With Insulin Analogs Lispro And Aspart With RHuP ...
  Fri, 03 September 2010
  Halozyme Therapeutics, Inc. (Nasdaq: HALO) announced the initiation of two Phase 2 Ultrafast Insulin treatment studies that utilize its rHuPH20 hyaluronidase enzyme (PH20) in combination with the two leading commercially available mealtime analogs: insulin aspart, the active ingredient in NovoLog, and insulin lispro, the ac ...
• Soligenix Announces Publication Of Article Identifying Domains Within The Ricin Toxin A ...
  Fri, 03 September 2010
  Soligenix, Inc. (OTC Bulletin Board: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company, announced the publication of an article online in Vaccine. The article describes the systematic identification of neutralizing and non-neutralizing B-cell epitopes on ricin toxin's enzymatic A subunit (RTA)...
• Transdel Pharmaceuticals Presents Phase 3 Study Data On Ketotransdel At World Pain Congr ...
  Fri, 03 September 2010
  Transdel Pharmaceuticals, Inc. (OTC Bulletin Board: TDLP), a specialty pharmaceutical company focused on developing topically administered products using its proprietary transdermal delivery platform, announced the final data set from its Phase 3 study of Ketotransdel (TDLP-110) at the 13th World Congress on Pain in Montrea ...
• New Research Demonstrates Safety Of Cord-blood-derived Stem Cell Treatments
  Fri, 03 September 2010
  In a new peer-reviewed article published by the Journal of Translational Medicine, scientists from Beike Biotechnology, China's leading stem cell research and regenerative medicine company, and Medistem, Inc...
• Technique That Could Resolve The Problem Of Fake Medicines In Developing Countries
  Fri, 03 September 2010
  Counterfeiting of drugs is a huge industry with an annual turnover of more than SEK 500 billion. In Africa the situation is extremely serious. Half of the malaria medication sold there could be ineffective or even harmful. Researchers from Lund and the UK have now developed a technique that could resolve the situation. In tw ...
• Orexigen Partners With Takeda To Commercialize Obesity Drug Contrave (Naltrexone SR/Bupr ...
  Thu, 02 September 2010
  Contrave (naltrexone SR/bupropion SR), an investigational drug aimed at combination therapy to address both biological and behavioral drivers of obesity, will be developed and commercialized by Orexigen Therapeutics, Inc. and Takeda Pharmaceutical Company Limited in the USA, Canada and Mexico. The two drug firms have just si ...
• Therapeutic Workshops To Highlight Opportunities In Biotech At 9th Annual BIO Investor Forum
  Thu, 02 September 2010
  BIO today announced the preliminary set of speakers who will be featured on the Therapeutic Workshops during the 9th Annual BIO Investor Forum - a national meeting focused on investment trends and opportunities in the life-sciences with a focus on public and venture-stage growth companies...
• Roche Provides Update On FDA Application For T-DM1
  Thu, 02 September 2010
  Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that the U.S. Food and Drug Administration (FDA) issued a Refuse to File letter for accelerated approval for the company's trastuzumab-DM1 (T-DM1) Biologics License Application (BLA). As planned Roche will continue with its ongoing Phase III EMILIA registration study...
• Novartis Drug Tasigna Approved In Switzerland After Fast-track Review For Treatment Of P ...
  Thu, 02 September 2010
  The Swiss health authority Swissmedic has granted approval for Tasigna (nilotinib) 300 mg twice daily for the treatment of adult patients with newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia (Ph CML) in chronic phase...